Market Cap 5.86M
Revenue (ttm) 20.76M
Net Income (ttm) -23.93M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -115.27%
Debt to Equity Ratio 2.97
Volume 134,900
Avg Vol 1,799,330
Day's Range N/A - N/A
Shares Out 10.04M
Stochastic %K 42%
Beta 0.95
Analysts Strong Sell
Price Target $3.00

Company Profile

DSS, Inc. operates in the product packaging, biotechnology, commercial lending, securities and investment management, and direct marketing businesses in the United States. The company manufactures, markets, and sells mailers, photo sleeves, custom folding cartons, and 3-dimensional direct mail solutions; and markets and distributes nutritional and personal care products. It invests in or acquires companies in the biohealth and biomedical fields, including businesses that focuses on the advanceme...

Industry: Packaging & Containers
Sector: Consumer Cyclical
Phone: 585 325 3610
Address:
275 Wiregrass Parkway, West Henrietta, United States
stevero
stevero Jul. 11 at 2:44 AM
$DSS D.S.S.SCUM 100% SCUM.
0 · Reply
johannn
johannn Jul. 9 at 10:14 PM
$DSS How can you be bullish now? The buyers of the shares that Chan sold for $7 to the small investor in 2020 have now dropped by 99.xx%. If this investor wants to get their investment back, the price needs to go to $150.00 because so many shares have been printed, since DSS bought worthless fake companies from the Chinese sewer rat Chan, sometimes with shares and sometimes with the cash that DSS raised by selling new shares to the small investor with false valuations.🥷🥷🕵️🕵️🧑‍🦯🧑‍🦯
0 · Reply
Johnny_Three_Sixteen
Johnny_Three_Sixteen Jul. 9 at 9:41 PM
$DSS Percent of class represented by amount in Row (11) 86.8 % https://www.sec.gov/Archives/edgar/data/771999/000149315226032713/xslSCHEDULE_13D_X02/primary_doc.xml
0 · Reply
johannn
johannn Jul. 9 at 9:38 PM
$DSS Dilution dilution dilution https://www.sec.gov/Archives/edgar/data/771999/000149315226032712/xslF345X06/ownership.xml
0 · Reply
johannn
johannn Jul. 9 at 4:02 PM
0 · Reply
veronik28
veronik28 Jul. 8 at 11:25 PM
$DSS Very volatile; traders may speculate, but dilution/news risk is high 👀
0 · Reply
topstockalerts
topstockalerts Jul. 8 at 12:02 PM
$DSS send it!!
1 · Reply
johannn
johannn Jul. 5 at 7:00 PM
$DSS https://www.sec.gov/ix?doc=/Archives/edgar/data/0000771999/000149315226030115/form8-k.htm Nope.....A mega dilution is coming. On June 23, 2026, DSS, Inc. (the “Company”) entered into a securities purchase agreement (the “SPA”) with Alset, Inc. (“Alset”), a Texas corporation, pursuant to which Alset will loan the Company $1,000,000, in exchange for a convertible promissory note (the “Note”) and warrants to purchase 17,777,776 shares of the Company's common stock pursuant to a warrant agreement (the “Warrant Agreement”).
0 · Reply
Danzzzzzzzz
Danzzzzzzzz Jul. 5 at 5:26 AM
$DSS yep
0 · Reply
Danzzzzzzzz
Danzzzzzzzz Jul. 5 at 5:26 AM
0 · Reply
Latest News on DSS
DSS, Inc. Withdraws Registration Statement

Jun 9, 2026, 10:15 AM EDT - 4 weeks ago

DSS, Inc. Withdraws Registration Statement


DSS, Inc. Quarterly report: Q1 2026

May 15, 2026, 7:00 AM EDT - 2 months ago

DSS, Inc. Quarterly report: Q1 2026


DSS, Inc. Registration statement: Registration filing

Apr 24, 2026, 8:00 AM EDT - 2 months ago

DSS, Inc. Registration statement: Registration filing


DSS, Inc. Registration statement: Registration filing

Apr 17, 2026, 8:00 AM EDT - 3 months ago

DSS, Inc. Registration statement: Registration filing


DSS, Inc. Annual report: Q4 2025

Mar 31, 2026, 7:00 AM EDT - 3 months ago

DSS, Inc. Annual report: Q4 2025


DSS, Inc. Announces Launch of Proposed Public Offering

Feb 3, 2026, 8:17 PM EST - 5 months ago

DSS, Inc. Announces Launch of Proposed Public Offering


DSS, Inc. Quarterly report: Q3 2025

Nov 14, 2025, 4:00 PM EST - 8 months ago

DSS, Inc. Quarterly report: Q3 2025


DSS, Inc. Proxy statement: Proxy Filing

Oct 21, 2025, 8:00 AM EDT - 9 months ago

DSS, Inc. Proxy statement: Proxy Filing


DSS, Inc. Proxy statement: Proxy Filing

Oct 20, 2025, 8:00 AM EDT - 9 months ago

DSS, Inc. Proxy statement: Proxy Filing


DSS, Inc. Quarterly report: Q2 2025

Aug 14, 2025, 7:00 AM EDT - 11 months ago

DSS, Inc. Quarterly report: Q2 2025


DSS, Inc. Quarterly report: Q1 2025

May 15, 2025, 4:00 PM EDT - 1 year ago

DSS, Inc. Quarterly report: Q1 2025


DSS, Inc. Annual report: Q4 2024

Mar 31, 2025, 8:00 AM EDT - 1 year ago

DSS, Inc. Annual report: Q4 2024


DSS announces sale of Celios to Impact BioMedical

2025-02-26T13:41:33.000Z - 1 year ago

DSS announces sale of Celios to Impact BioMedical

IBO


DSS, Inc. Issues Letter to Shareholders

Feb 3, 2025, 8:50 AM EST - 1 year ago

DSS, Inc. Issues Letter to Shareholders


DSS, Inc. Quarterly report: Q3 2024

Nov 14, 2024, 12:30 PM EST - 1 year ago

DSS, Inc. Quarterly report: Q3 2024


DSS, Inc. Registration statement: Registration Filing

Oct 31, 2024, 8:00 AM EDT - 1 year ago

DSS, Inc. Registration statement: Registration Filing


DSS, Inc. Proxy statement: Proxy Filing

Oct 22, 2024, 8:00 AM EDT - 1 year ago

DSS, Inc. Proxy statement: Proxy Filing


DSS, Inc. Registration statement: Registration Filing

Sep 6, 2024, 8:00 AM EDT - 2 years ago

DSS, Inc. Registration statement: Registration Filing


DSS, Inc. Names Jason Grady as Interim Chief Executive Officer

Aug 26, 2024, 4:08 PM EDT - 2 years ago

DSS, Inc. Names Jason Grady as Interim Chief Executive Officer


DSS, Inc. Quarterly report: Q2 2024

Aug 12, 2024, 6:00 PM EDT - 2 years ago

DSS, Inc. Quarterly report: Q2 2024


DSS, Inc. Quarterly report: Q1 2024

May 14, 2024, 4:00 PM EDT - 2 years ago

DSS, Inc. Quarterly report: Q1 2024


DSS, Inc. Earnings release: Q1 2024

May 14, 2024, 4:00 PM EDT - 2 years ago

DSS, Inc. Earnings release: Q1 2024


DSS, Inc. Earnings release: Q4 2023

Mar 27, 2024, 8:00 AM EDT - 2 years ago

DSS, Inc. Earnings release: Q4 2023


DSS, Inc. Annual report: Q4 2023

Mar 27, 2024, 8:00 AM EDT - 2 years ago

DSS, Inc. Annual report: Q4 2023


DSS, Inc. Quarterly report: Q3 2023

Nov 14, 2023, 12:00 AM EST - 2 years ago

DSS, Inc. Quarterly report: Q3 2023


DSS, Inc. Earnings release: Q3 2023

Nov 14, 2023, 12:00 AM EST - 2 years ago

DSS, Inc. Earnings release: Q3 2023


DSS Inc. Issues Letter to Shareholders

Oct 12, 2023, 8:25 AM EDT - 2 years ago

DSS Inc. Issues Letter to Shareholders


DSS, Inc. Proxy statement: Proxy Filing

Sep 12, 2023, 8:00 AM EDT - 3 years ago

DSS, Inc. Proxy statement: Proxy Filing


DSS, Inc. Quarterly report: Q2 2023

Aug 14, 2023, 7:00 AM EDT - 3 years ago

DSS, Inc. Quarterly report: Q2 2023


DSS, Inc. Earnings release: Q2 2023

Aug 14, 2023, 7:00 AM EDT - 3 years ago

DSS, Inc. Earnings release: Q2 2023


DSS, Inc. Quarterly report: Q1 2023

May 16, 2023, 7:00 AM EDT - 3 years ago

DSS, Inc. Quarterly report: Q1 2023


DSS, Inc. Earnings release: Q1 2023

May 16, 2023, 7:00 AM EDT - 3 years ago

DSS, Inc. Earnings release: Q1 2023


DSS, Inc. Annual report: Q4 2022

Mar 31, 2023, 7:00 AM EDT - 3 years ago

DSS, Inc. Annual report: Q4 2022


DSS, Inc. Earnings release: Q4 2022

Mar 31, 2023, 7:00 AM EDT - 3 years ago

DSS, Inc. Earnings release: Q4 2022


DSS Announces Letter to Shareholders

Mar 2, 2023, 8:30 AM EST - 3 years ago

DSS Announces Letter to Shareholders


DSS, Inc. Quarterly report: Q3 2022

Nov 14, 2022, 7:00 AM EST - 3 years ago

DSS, Inc. Quarterly report: Q3 2022


DSS, Inc. Earnings release: Q3 2022

Nov 14, 2022, 7:00 AM EST - 3 years ago

DSS, Inc. Earnings release: Q3 2022


DSS, Inc. Proxy statement: Proxy Filing

Oct 21, 2022, 8:00 AM EDT - 4 years ago

DSS, Inc. Proxy statement: Proxy Filing


DSS, Inc. Quarterly report: Q2 2022

Sep 14, 2022, 7:00 AM EDT - 4 years ago

DSS, Inc. Quarterly report: Q2 2022


DSS, Inc. Earnings release: Q2 2022

Sep 14, 2022, 7:00 AM EDT - 4 years ago

DSS, Inc. Earnings release: Q2 2022


DSS, Inc. Quarterly report: Q1 2022

May 16, 2022, 8:30 AM EDT - 4 years ago

DSS, Inc. Quarterly report: Q1 2022


DSS, Inc. Earnings release: Q1 2022

May 16, 2022, 8:30 AM EDT - 4 years ago

DSS, Inc. Earnings release: Q1 2022


DSS, Inc. Proxy statement: Proxy Filing

May 9, 2022, 8:00 AM EDT - 4 years ago

DSS, Inc. Proxy statement: Proxy Filing


DSS, Inc. Proxy statement: Proxy Filing

Apr 26, 2022, 8:00 AM EDT - 4 years ago

DSS, Inc. Proxy statement: Proxy Filing


DSS, Inc. Proxy statement: Proxy Filing

Apr 15, 2022, 8:00 AM EDT - 4 years ago

DSS, Inc. Proxy statement: Proxy Filing


DSS, Inc. Proxy statement: Proxy Filing

Apr 4, 2022, 8:00 AM EDT - 4 years ago

DSS, Inc. Proxy statement: Proxy Filing


DSS, Inc. Annual report: Q4 2021

Mar 31, 2022, 8:00 AM EDT - 4 years ago

DSS, Inc. Annual report: Q4 2021


CORRECTION - DSS Announces Letter to Shareholders

Feb 28, 2022, 5:15 PM EST - 4 years ago

CORRECTION - DSS Announces Letter to Shareholders


DSS to Present at Aegis Virtual Conference

Feb 22, 2022, 5:00 PM EST - 4 years ago

DSS to Present at Aegis Virtual Conference


DSS, Inc. Proxy statement: Proxy Filing

Jan 24, 2022, 7:00 AM EST - 4 years ago

DSS, Inc. Proxy statement: Proxy Filing


DSS Acquires 25.1% of Alset International Limited

Jan 19, 2022, 12:13 PM EST - 4 years ago

DSS Acquires 25.1% of Alset International Limited


Impact BioMedical Announces New Bioplastics Test Results

Jan 11, 2022, 10:00 AM EST - 4 years ago

Impact BioMedical Announces New Bioplastics Test Results


DSS Enters Quantitative Investment Fund Arena

Nov 30, 2021, 7:30 AM EST - 5 years ago

DSS Enters Quantitative Investment Fund Arena


DSS, Inc. Proxy statement: Proxy Filing

Oct 1, 2021, 8:00 AM EDT - 5 years ago

DSS, Inc. Proxy statement: Proxy Filing


stevero
stevero Jul. 11 at 2:44 AM
$DSS D.S.S.SCUM 100% SCUM.
0 · Reply
johannn
johannn Jul. 9 at 10:14 PM
$DSS How can you be bullish now? The buyers of the shares that Chan sold for $7 to the small investor in 2020 have now dropped by 99.xx%. If this investor wants to get their investment back, the price needs to go to $150.00 because so many shares have been printed, since DSS bought worthless fake companies from the Chinese sewer rat Chan, sometimes with shares and sometimes with the cash that DSS raised by selling new shares to the small investor with false valuations.🥷🥷🕵️🕵️🧑‍🦯🧑‍🦯
0 · Reply
Johnny_Three_Sixteen
Johnny_Three_Sixteen Jul. 9 at 9:41 PM
$DSS Percent of class represented by amount in Row (11) 86.8 % https://www.sec.gov/Archives/edgar/data/771999/000149315226032713/xslSCHEDULE_13D_X02/primary_doc.xml
0 · Reply
johannn
johannn Jul. 9 at 9:38 PM
$DSS Dilution dilution dilution https://www.sec.gov/Archives/edgar/data/771999/000149315226032712/xslF345X06/ownership.xml
0 · Reply
johannn
johannn Jul. 9 at 4:02 PM
0 · Reply
veronik28
veronik28 Jul. 8 at 11:25 PM
$DSS Very volatile; traders may speculate, but dilution/news risk is high 👀
0 · Reply
topstockalerts
topstockalerts Jul. 8 at 12:02 PM
$DSS send it!!
1 · Reply
johannn
johannn Jul. 5 at 7:00 PM
$DSS https://www.sec.gov/ix?doc=/Archives/edgar/data/0000771999/000149315226030115/form8-k.htm Nope.....A mega dilution is coming. On June 23, 2026, DSS, Inc. (the “Company”) entered into a securities purchase agreement (the “SPA”) with Alset, Inc. (“Alset”), a Texas corporation, pursuant to which Alset will loan the Company $1,000,000, in exchange for a convertible promissory note (the “Note”) and warrants to purchase 17,777,776 shares of the Company's common stock pursuant to a warrant agreement (the “Warrant Agreement”).
0 · Reply
Danzzzzzzzz
Danzzzzzzzz Jul. 5 at 5:26 AM
$DSS yep
0 · Reply
Danzzzzzzzz
Danzzzzzzzz Jul. 5 at 5:26 AM
0 · Reply
Danzzzzzzzz
Danzzzzzzzz Jul. 5 at 5:26 AM
0 · Reply
Danzzzzzzzz
Danzzzzzzzz Jul. 5 at 5:26 AM
0 · Reply
Danzzzzzzzz
Danzzzzzzzz Jul. 5 at 5:25 AM
0 · Reply
Danzzzzzzzz
Danzzzzzzzz Jul. 5 at 5:25 AM
0 · Reply
johannn
johannn Jul. 1 at 6:40 PM
$IBO $DSS $AEI $HWH Well, well, it’s already been over a year and still no strategic merger https://www.impactbiomedinc.com/dr-ashleys-limited-and-impact-biomedical-inc-announce-strategic-merger/ And on April 03, 2026 at 13:52 ET another worthless press release came from these scammers, in which we are lied to about a new date again, namely .... Separately, Impact Biomedical continues with strategic plans to merge with Dr. Ashley’s Ltd. (here), projected to be completed by July 1, 2026. https://www.globenewswire.com/news-release/2026/04/03/3268111/0/en/impact-biomedical-inc-reports-going-concern-audit-opinion-in-2025-10-k-filing-while-continuing-strategic-merger-plans.html It appears that the merger involving the two fraudulent companies IBO and Dr Ashley, which is now called Zoar Inc. after a name change, will not go ahead; that was, of course, to be expected.🕵️🕵️🥷🥷
0 · Reply
JoaoCarvalho
JoaoCarvalho Jul. 1 at 9:22 AM
$DSS When moon?
0 · Reply
JohnQpub
JohnQpub Jun. 30 at 7:23 PM
$DSS 16% short nibble nibble
1 · Reply
johannn
johannn Jun. 25 at 8:33 PM
$DSS $IBO $AEI $HWH As was to be expected, since the real market is not interested in these scam stocks, they just continue shuffling junk around among themselves to let the dilution continue. https://www.sec.gov/ix?doc=/Archives/edgar/data/0000771999/000149315226030115/form8-k.htm
0 · Reply
TempleofBoom
TempleofBoom Jun. 18 at 2:04 PM
$DSS 0.58
0 · Reply
JoaoCarvalho
JoaoCarvalho Jun. 13 at 11:11 PM
$DSS Can we go to 0.85 next week?
0 · Reply
jucebot
jucebot Jun. 12 at 5:53 PM
Jovanotti loaded up a long in $DSS @ $0.63 $MAAS $UBXG
0 · Reply
jucebot
jucebot Jun. 12 at 3:25 PM
Jovanotti just scaled into a long on $POET @ $12.83 $AXTX $CIIT $CRWU $DSS $RKDA
0 · Reply